Raji completed her PhD at UQ in 2021. With extensive experience in scientific research and industry, Raji joined the Ngo Group in 2021 to investigate the therapeutic potential of lead compounds for the treatment of MND. Her project is supported by Aeterna Zentaris Inc; we are currently conducting pre-clinical validation of the lead compound, with the view to progress this treatment into clinical trial phases for people living with MND.